Morgan Stanley upgrades insurer Lemonade to 'equal-weight'
- Gold Price Forecast: US Non-Farm Payrolls Miss Expectations, Gold Surges Over $100, Can the Bull Run Continue?
- Iran insists on control of Hormuz amid reports of US talks
- Gold gains momentum above $4,100 after weak US NFP data
- June Non-Farm Payrolls Preview: Did White House Economic Advisor Give an Early Hint? How Will US Stocks, Dollar and Gold React?
- WTI slips below $68.00 as supply concerns ease
- Bitcoin Price Trend Forecast: Continued ETF Outflows Limit Bitcoin Price Rebound Space, $58,000 Becomes Key Level for Bulls and Bears

Investing.com - Morgan Stanley on Wednesday said it was upgrading insurer Lemonade Inc (NYSE:LMND) to "equal-weight" from "underweight" and raised its price target to $42 from $23.
Shares of Lemonade rose 17.2% at $47, with stock more than doubled in value year to date.
Lemonade at its investor day unveiled plan to grow its business from $1 billion in premiums to $10 billion over the next few years.
The insurance technology company plans to achieve these goals by leveraging advanced technology, improving operational efficiency, and focusing on auto insurance growth. Lemonade's updated guidance also projects a 30% annual growth rate in in-force premiums (IFP), reaching $2 billion by 2027.
Morgan Stanley (NYSE:MS) cited optimism about the company’s profitability timeline, which surpasses market expectations. The bank highlighted Lemonade’s plans for significant expense efficiencies as key to hitting these targets.
For 2025, Lemonade forecasts 50% adjusted gross profit growth, $1.2 billion in IFP, and positive adjusted free cash flow, despite operating in an increasingly competitive auto insurance market.
While Morgan Stanley the most important element of the investor day for it was the goal to achieve net profit exiting 2027, which is significantly better than Wall Street consensus and its expectations.
Read more
* The content presented above, whether from a third party or not, is considered as general advice only. This article should not be construed as containing investment advice, investment recommendations, an offer of or solicitation for any transactions in financial instruments.




